Advanced search
Publication Cover
Pharmacogenomics Volume 6, 2005 - Issue 8
Submit an article Journal homepage
362
Views
1
CrossRef citations to date
0
Altmetric
Research Report

Physiogenomic Analysis Links Serum Creatine Kinase Activities During Statin Therapy to Vascular Smooth Muscle Homeostasis

Gualberto Ruaño1 Genomas, Inc., 67 Jefferson St., Hartford, CT06106, USA.Correspondence[email protected]
,
Paul D Thompson2 Hartford Hospital, Hartford, CT, USA
,
Andreas Windemuth1 Genomas, Inc., 67 Jefferson St., Hartford, CT06106, USA.
,
Andrew Smith3 University of California, Department of Laboratory Medicine, San Francisco and the San Francisco General Hospital, San Francisco, CA, USA
,
Mohan Kocherla1 Genomas, Inc., 67 Jefferson St., Hartford, CT06106, USA.
,
Theodore R Holford4 Yale University School of Medicine, New Haven, CT, USA
,
Richard Seip2 Hartford Hospital, Hartford, CT, USA
&
Alan HB Wu3 University of California, Department of Laboratory Medicine, San Francisco and the San Francisco General Hospital, San Francisco, CA, USA
 show all
Pages 865-872 | Published online: 21 Nov 2005

Bibliography

  • Sacks FM , PfefferMA, MoyeLA et al.: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N. Engl. J. Med.335, 1001–1009 (1996).
  • Shepherd J : Statin therapy in clinical practice: new developments.Curr. Opin. Lipidol.6(5), 254–255 (1995).
  • Downs JR , ClearfieldM, WeisS et al.: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.JAMA279(20), 1615–1622 (1998).
  • Thompson PD , ClarksonP, KarasRH: Statin-associated myopathy.JAMA289,1681–1690 (2003).
  • Staffa JA , ChangJ, GreenL: Cerivastatin and reports of fatal rhabdomyolysis.N. Engl. J. Med. 346, 539–540 (2002).
  • Rosenson RS : Current overview of statin-induced myopathy.Am. J. Med.116(6), 408–416 (2004).
  • Wilke RA , MooreJH, BurmesterJK: Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage.Pharmacogenet. Genomics15(6), 415–421 (2005).
  • Guijarro C, Blanco-Colio LM, Ortego M et al.: 3-hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation induce apoptosis of vascular smooth muscle cells in culture. Circ. Res.83(5)490–500 (1998).
  • Knapp AC , HuangJ, StarlingG, KienerPA: Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death.Atherosclerosis152, 217–227 (2000).
  • Ruaño G , WindemuthA, HolfordT: Physiogenomics: integrating systems engineering and nanotechnology for personalized health. In:The Biomedical Engineering Handbook, 3rd Edition. CRC Press, FL, USA (2005) (In press).
  • Saltelli A , ChanK, ScottEM: Sensitivity Analysis. John Wiley and Sons, Chichester, UK (2000).
  • Murphy TJ , AlexanderRW, GriendlingKK, RungeMS, BernsteinKE: Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor.Nature351, 233–236 (1991).
  • Zöllner S , HaseloffRF, KirilyukIA, Blasig IE, Rubanyi GM: Nitroxides increase the detectable amount of nitric oxide released from endothelial cells. J. Biol. Chem.272, 23076–23080 (1997).
  • Carmeliet P : Angiogenesis in health and disease.Nature Med.9, 653–660 (2003).
  • Kendall RL , WangG, ThomasKA: Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR.Biochem. Biophys. Res. Commun.226, 324–328 (1996).
  • Ahn D , GeY, StricklettPK et al.: Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention.J. Clin. Invest. 114, 504–511 ( 2004).
  • Imanishi T , HanoT, SawamuraT, Takarada S, Nishio I: Oxidized low density lipoprotein potentiation of Fas-induced apoptosis through lectin-like oxidized-low density lipoprotein receptor-1 in human umbilical vascular endothelial cells. Circ. J.66(11), 1060–1064 (2002).
  • D‘Introno A , SolfrizziV, ColaciccoAM et al.: Polymorphisms in the oxidized low-density lipoprotein receptor-1 gene and risk of Alzheimer‘s disease. J. Gerontol. A. Biol. Sci. Med. Sci.60(3),280–284 (2005).
  • Marshal LJ Ramdin, Lara SP, Brooks T, Charlton Dphil P, Shute JK: Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes. J. Immunol.171, 2057–2065 (2003).
  • Oliphant A , BarkerDL, StuelpnagelJR, CheeMS: BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping.Biotechniques32, S56–S61 (2002).
  • Fan JB , OliphantA, ShenR et al.: Highly parallel SNP genotyping. Cold Spr. Harb. Symp. Biol. 68, 69–78 (2003).
  • Reinere A , YekutieleD, BenjaminiY: Identifying differentially expressed genes using false discovery rate controlling procedures.Bioinformatics19,368–375 (2003).
  • Benjamini Y , HochbergY: Controlling the false discovery rate: a practical and powerful approach to multiple testing.J. R. Stat. Soc. (Ser B)57,289–300 (1995).
  • Benjamini Y , HochbergY: On the adaptive control of the false discovery rate in multiple testing with independent statistics.J. Education Behav. Stat.25, 60–83 (2000).
  • Rosner B : Fundamentals of Biostatistics. Wadsworth Publishing Co., Belmont, CA, USA (1995).
  • Cleveland WS : Robust locally weighted regression and smoothing scatterplots.J. Am. Stat. Assoc.74,829–836 (1979).
  • Cleveland WS , DevlinSJ: Locally weighted regression: an approach to regression analysis by local fitting.J. Am. Stat. Assoc.83, 596–610 (1988).
  • Rubanyi GM : Endothelium-derived relaxing and contracting factors.J. Cell. Biochem.46,27–36 (1991).
  • Holash J , WiegandSJ, YancopoulosGD: New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.Oncogene18(38), 5356–5362 (1999).
  • Kwak HJ , SoJN, LeeSJ, KimI, KohGY: Angiopoietin-1 is an apoptosis survival factor for endothelial cells.FEBS Lett.448(2–3), 249–253 (1999).
  • Kato K, Shimizu A, IshiguroY, Mokuno K, Ariyoshi Y, Nakajima T: Highly sensitive enzyme immunoassayfor human creatine kinase BB enzyme. Clin. Chim. Acta. 150(1) , 31–40 (1985).
  • Clark JF : The creatine kinase system in smooth muscle.Mol. Cell Biochem.133–134,221–232 (1994).
  • Hoag GN , FranksCR, SmithC, DeCoteau WE: Creatine kinase isoenzyme patterns in normal smooth muscle and smooth muscle neoplasms. Clin. Biochem.13(4), 149–150 (1980).
  • Holford TR, Windemuth A, Ruaño G: Personalizing public health. Personalized Medicine2(3),239–249 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.